Nutex Health Inc. · NASDAQ:NUTX
Nutex Health — Investor Presentation (August 2026)
16 slides from Nutex Health's investor presentation, August 2026
Slide 1: Strictly Private and Confidential
STRICTLY PRIVATE AND CONFIDENTIAL STRICTLY PRIVATE AND CONFIDENTIAL
Slide 2: Disclaimer
Disclaimer General The information contained in this Investor Presentation (“Presentation”) has been prepared by Nutex Health Inc. (“NUTX” or the “Company”) for investors, solely for informational purposes. The Presentation has been prepared to assist prospective investors in making their own evalua
Slide 3: Forward looking statements
Forward looking statements Certain statements and information included in this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Act of 1995. When used in this presentation, the words or phrases “will”, “will likely result” “expected to,” “w
Slide 4: Agenda
Agenda 1 Business Overview 2 Appendix CONFIDENTIAL 4
Slide 5: Management Team With Deep Experience in Healthcare
Management Team With Deep Experience in Healthcare Thomas T. Vo, M.D., MBA Warren Hosseinion, M.D. Jon Bates, MBA, CPA Wesley Bamburg, FACHE Chief Executive Officer President Chief Financial Officer Chief Operating Officer Master of Business Administration ER Physician CEO Co-Founder & CEO VP of Acc
Slide 6: Our mission, vision, and values
Our mission, vision, and values Our Mission To make exceptional concierge-level health care more accessible to all communities, with a practice centered on patient experience and satisfaction Our Vision To be leaders and innovators in the small hospital space Our Values Patient care is our number on
Slide 7: Nutex at-a-glance
Nutex at-a-glance Owns and operates a comprehensive and integrated care delivery platform comprised of: Company Highlights Hospital Division – Develops and operates a network of micro-hospitals, specialty hospitals, and hospital outpatient departments – A micro-hospital is a small hospital inclu
Slide 8: Overview of Nutex’s hospital division
Overview of Nutex’s hospital division Nutex’s Innovative Micro-Hospitals Meet their served Communities Demand for Higher Acuity Care Address Challenges of Traditional Care Access Points Network of strategically located, state-of-the-art micro-hospitals across the U.S. which service ER visits at eq
Slide 9: Nutex’s micro-hospitals treat ER acuities at a fraction of the wait time
Nutex’s micro-hospitals treat ER acuities at a fraction of the wait time Nutex’s facilities require lower staffing and capital obligations while delivering improved quality of care, with an average patient wait time under 30 minutes The majority of cases treated at a Nutex micro-hospital are acuity
Slide 10: Turn-key de novo strategy delivering compelling and scalable facility economics
Turn-key de novo strategy delivering compelling and scalable facility economics De Novo Facility Profile De Novo Rollout Timeline Provide emergency, inpatient care, outpatient imaging, outpatient Task Timing labs, minor procedures, etc. Services / Staffing ER Physician, RNs, Radiology Technologi
Slide 11: Overview of Nutex’s population health management division
Overview of Nutex’s population health management division Nutex operates 4 IPAs: Company Highlights Clinical quality reporting (STAR, HEDIS, MIPS, ACO reports) Nutex IPAs (Independent Practice Associations) AHP IPA (Los Angeles): 30,000+ patients, 140+ primary care physicians, 400+ specialis
Slide 12: Selected External Growth Opportunities
Selected External Growth Opportunities Core Nutex Opportunities Emerging Nutex and Micro-Hospital Opportunities IPA Development Joint Ventures Acquire or start IPAs Develop and operate facilities on behalf of health Increase capitation and full-risk contracting systems Facility Development Dig
Slide 13: Financial Overview
Financial Overview Historical Financials - Annual Commentary FULL YEAR 2025 HIGHLIGHTS: • Total revenue of $875.3 million for the year 2025 ($ in millions) versus $479.9 million for the year 2024, an increase of 82.4% • Net income attributable to Nutex Health of $70.8 million for 2025 versus net inc
Slide 14: Financial Overview
Financial Overview Historical Financials - Quarterly Commentary Financial highlights for the three months ended June 30, 2026 • Net income attributable to Nutex Health increased ($ in millions) to $65.8 million, or diluted EPS of $9.38, compared to a loss of $17.7 million, or diluted EPS of $(2.95),
Slide 15: Board of Directors With Deep Experience in Healthcare
Board of Directors With Deep Experience in Healthcare Thomas T. Vo, M.D., MBA Chief Executive Officer Scott J. Saunders Kelvin Spears, M.D. Director Director o Mr. Saunders is head of health care advisory services and has been Managing o Dr. Spears is Board Certified in Emergency Medicine and has ov
Slide 16: Investment Highlights
Investment Highlights Well-positioned for major trends in a large and attractive market (high-quality, medium-acuity patient- 1 centric hospital with inpatient care and value-based outpatient care) Deep value proposition to the healthcare ecosystem from our comprehensive portfolio of coordinated 2 a